PharmaCielo (PCLOF) News
Latest news and analysis
PharmaCielo Plunges 26.4% as CBD Stock Hits New Lows
PCLOF shares tumbled to $0.04 amid continued pressure on CBD sector valuations and limited financial transparency.
PharmaCielo Crashes 26.4% as Cannabis Stock Hits New Lows
PharmaCielo shares plummeted to $0.04, marking another significant decline for the struggling cannabis company amid broader sector weakness.
PharmaCielo Crashes 26.4% as CBD Stock Hits Near Historic Lows
PCLOF shares plummeted to $0.04 amid elevated volume, trading near 52-week lows as the Colombian cannabis company faces mounting market pressures.
PharmaCielo Crashes 26.4% as CBD Stock Hits New Lows
PharmaCielo shares plummeted to $0.04 amid elevated trading volume, reflecting ongoing challenges in the CBD sector.
PharmaCielo Crashes 26.4% as CBD Stock Hits Critical Support
PharmaCielo plummeted to $0.04 per share on elevated volume, marking a significant breach of technical support levels amid ongoing sector headwinds.
PharmaCielo Crashes 26.4% as CBD Stock Hits Near 52-Week Lows
PCLOF shares plummeted to $0.04 amid continued pressure on cannabis sector valuations and company-specific headwinds.
PharmaCielo Crashes 26.4% as CBD Sector Faces Mounting Pressure
PharmaCielo shares plummeted to $0.04 amid continued sector headwinds and penny stock volatility concerns.
PharmaCielo Crashes 26% as CBD Stock Hits New Lows
PharmaCielo shares plummeted 26.4% to $0.04, bringing the Colombian cannabis company's market cap down to just $7.4 million amid ongoing sector struggles.
PharmaCielo Crashes 26% as Cannabis Stock Hits Near 52-Week Lows
PCLOF shares plummeted to $0.04 amid heavy selling pressure, bringing market cap down to just $7.4M as investors flee micro-cap cannabis names.
PharmaCielo Plunges 26.4% as CBD Stock Hits Near 52-Week Lows
PharmaCielo shares crashed to $0.04 amid heightened selling pressure, bringing the Colombian cannabis company's market cap to just $7.4 million.
PharmaCielo Plunges 26.4% as Cannabis Stock Hits New Lows
PCLOF shares collapsed to $0.04 amid heavy selling pressure, bringing market cap down to just $7.4 million as the Colombian cannabis producer faces mounting challenges.